Chronic insomnia is a persistent difficulty initiating sleep, maintaining sleep, or achieving restorative sleep, occurring at least three nights per week for three months or longer, with significant daytime impairment. A key clinical feature—highlighted by the “always braced” body—is physiologic hyperarousal: autonomic activation (e.g., elevated sympathetic tone), increased cortical alertness, and heightened stress reactivity. This state can become self-perpetuating. When insomnia is chronic, the brain and body may treat bedtime as a threat signal, maintaining wake-like neurobiological activity during periods that would normally downshift. This sustained vigilance can help explain why insomnia often co-occurs with depressive disorders and, in some patients, why improving sleep may also reduce depressive symptoms.
From a mechanistic standpoint, chronic insomnia influences multiple systems relevant to mood regulation. First, sleep restriction and fragmentation impair emotional processing in limbic circuits, including amygdala reactivity and prefrontal regulatory control. Under conditions of sleep loss, negative emotional stimuli are more salient and cognitive reappraisal becomes less effective, increasing vulnerability to depressed affect. Second, insomnia disrupts homeostatic and circadian regulation. Circadian misalignment—such as inconsistent wake times or delayed circadian phase—can alter timing of melatonin secretion, shift core body temperature rhythms, and change the stability of endocrine signals that support mood. Third, insomnia alters stress physiology. Elevated evening cortisol patterns and dysregulated hypothalamic-pituitary-adrenal (HPA) axis activity have been observed in insomnia and major depression, suggesting overlapping pathways of chronic stress burden.
Neurotransmitter and neuroinflammatory models provide additional explanatory layers. Insomnia is associated with irregularities in serotonergic, GABAergic, and glutamatergic signaling, systems central to arousal inhibition and sleep initiation. Such imbalances can contribute to both hyperarousal and impaired reward processing, both of which are common in depression. In parallel, sleep loss may increase pro-inflammatory cytokine activity (e.g., IL-6, TNF-alpha), and systemic inflammation can influence sickness behavior and depressive symptom dimensions. While inflammation is not the sole cause of depression, it can function as a biological amplifier of mood dysregulation.
The bidirectional relationship between insomnia and depression is clinically important. Depression increases the risk of insomnia through factors such as rumination, low motivation affecting sleep hygiene, anhedonia that disrupts behavioral rhythms, and altered circadian timing. Conversely, insomnia can precipitate or worsen depression by undermining emotional regulation, reducing resilience to stress, and increasing perceived helplessness through repeated nights of perceived failure. This reciprocal cycle is often maintained by conditioned arousal: the individual may develop conditioned wakefulness associated with bed and bedtime, leading to cognitive hyperactivity, frequent awakenings, and anxiety about sleep.
A particularly practical framework for treatment is the emphasis on cognitive and behavioral maintenance factors. In cognitive behavioral therapy for insomnia (CBT-I), core components include stimulus control (reassociating bed with sleep rather than wakefulness), sleep restriction therapy (consolidating sleep by limiting time in bed initially), cognitive restructuring (challenging catastrophic beliefs about sleeplessness), and relaxation strategies. These interventions aim to reduce hyperarousal, restore sleep homeostasis, and re-stabilize circadian timing. Because depression is closely tied to arousal level, negative affect reactivity, and reward-related neurocircuit function, lowering insomnia severity can reduce depressive symptoms even when the mood disorder is not directly targeted.
Evidence for sleep-focused benefits in depression includes randomized trials and observational studies showing that CBT-I can improve depressive outcomes in patients with comorbid insomnia and depression. While not all patients respond equivalently, symptom trajectories often parallel improvements in sleep continuity and perceived sleep quality. Importantly, insomnia treatment may also improve tolerability of antidepressant regimens, because better sleep can reduce daytime impairment and limit withdrawal from pleasurable activities.
Clinically, the “always braced” presentation should prompt assessment for insomnia subtype (sleep-onset vs sleep-maintenance vs early-morning awakening), severity, comorbid anxiety, bipolar spectrum risk, substance use, restless legs symptoms, sleep apnea, and medication effects (e.g., stimulants, corticosteroids). Additionally, screening for suicidal ideation is essential when depressive symptoms are prominent.
When considering treatment, CBT-I is first-line for chronic insomnia and is compatible with depression care plans. Pharmacotherapy may be used short-term in select cases, but the goal is sustainable restoration of sleep regulation. Patients should also practice consistent wake times, morning light exposure, limiting late caffeine and alcohol, and reducing time awake in bed. Addressing depression-related behaviors—social withdrawal, inactivity, and cognitive rumination—further supports sleep recovery.
In summary, chronic insomnia can maintain a physiologic and cognitive hyperarousal state that destabilizes emotional regulation, circadian biology, stress-system function, and inflammatory signaling—processes that converge with depression. Improving sleep can therefore act as a biological and behavioral intervention that reduces depressive vulnerability, disrupts the insomnia-depression feedback loop, and supports recovery of mood. Source: [OwenGregorian]
Owen Gregorian: Why Fixing a Person’s Sleep Might Also Lift Their Depression | Ben Sullivan, ScienceBlog The body of someone with chronic insomnia is, in a sense, always braced. Heart rate a touch high, mind refusing to idle, muscles never quite letting go, even at 3am when nothing is happening. #breaking
— @OwenGregorian May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
